Dr. Minniti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
174 Democrat Rd
Mickleton, NJ 08056Phone+1 856-423-0754Fax+1 856-423-7508- Is this information wrong?
Education & Training
- Temple University HospitalFellowship, Hematology and Medical Oncology, 1989 - 1992
- Fox Chase Cancer CenterFellowship, Medical Oncology, 1989 - 1992
- Rutgers Health/New Jersey Medical SchoolResidency, Internal Medicine, 1986 - 1989
- Ponce Health Sciences University School of MedicineClass of 1986
- Saint Joseph's UniversityBS, Biology, 1978 - 1982
Certifications & Licensure
- NJ State Medical License 1988 - 2025
- PA State Medical License 1989 - 2024
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- David King Community Clinical Scientist National Award ACCC Association of Community Cancer Centers, 2010
- Physician of the Year New Jersey Hospice & Palliative Care Organization, 2012
- Service to Mankind Award The Leukemia & Lymphoma Society Southern New Jersey Chapter, 2001
- Join now to see all
Clinical Trials
- Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors Start of enrollment: 2023 Jul 13
Roles: Principal Investigator
- Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection Start of enrollment: 2022 Aug 01
- Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies
- Join now to see all
Publications & Presentations
PubMed
- 9 citationsVinblastine and estramustine phosphate in metastatic renal cell carcinoma: a phase II trial of the Fox Chase Network.Naomi B. Haas, Bruce J. Giantonio, Samuel Litwin, C. Minniti, Stephen Fox, Gwen Yeslow, Robert Reilly, Kenneth Nahum, Richard E. Greenberg, Theresa Halbherr, Gary R. H...> ;Cancer. 2003 Nov 1
- 3 citationsPhase I trial of etoposide, doxorubicin and cisplatin (EAP) in combination with GM-CSFP.A. Ford, S.G. Arbuck, C. Minniti, L.L. Miller, D. Demaria, Peter J. O'Dwyer> ;European Journal of Cancer. 1996 Apr 1
- 162 citationsClopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase.D C Mills, Rajinder N. Puri, Chang-Jun Hu, C. Minniti, G Grana, M D Freedman, Roberta F. Colman, Robert W. Colman> ;Arteriosclerosis and Thrombosis. 1992 Apr 1
Journal Articles
- Activity of topotecan 21-day infusion in patients with previously treated large cell lymphoma: long-term follow-up of an Eastern Cooperative Group study (E5493)Wiernik PH, Li H, Weller E, Hochster HS, Horning SJ, Nazeer T, Gordon L, Haberman T, Minniti CJ Jr, Shapiro GR, Cassileth PA, Leukemia & Lymphoma, 1/1/2012
- Phase III toxicity trial of carboplatin (Cb) plus either Docetaxel (D) or paclitaxel (P) in advanced non-small cell lung cancer (NSCLC): Final results of OPN 001Langer CJ, Babb J, Minniti C, et al, Lung Cancer, 1/1/2003
- Vinblastine and estramustine phosphate in metastatic renal cell carcinoma; A phase II trial of the Fox Chase NetworkHaas N, Giantonio BJ, Litwin S, Minniti Jr CJ, Fox S, Yeslow G, Reilly R, Nahum K, Greenberg R, Halbherr T, Hudes GR, CA: A Cancer Journal for Clinicians, 1/1/2003
- Join now to see all
Books/Book Chapters
Committees
- Chair, Cancer Committee Inspira Medical Center Mullica Hill 1998 - Present
- Chair, Tumor Board Inspira Medical Center Mullica Hill 1997 - Present
Professional Memberships
- Fellow
- Member
Other Languages
- Spanish
Hospital Affiliations
- Inspira Medical Center-ElmerElmer, New Jersey
- Inspira Medical Center-VinelandVineland, New Jersey
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: